Cliff Murphy, MBA
Managing Director United Kingdom
+44 (20) 81 44 36 00
Curriculum vitae & references Quickcontact
To say that medical therapeutic and diagnostic devices have revolutionized healthcare would be an understatement. Digital technology now underpins the modern medical device landscape. Companies in this sector deliver exceptional value to healthcare providers and patients alike by enhancing diagnostic accuracy, improving therapeutic outcomes, and maintaining high standards of safety and efficacy. ConAlliance on the one hand assists in selling companies, but on the other hand also drives innovation in the medical device industry by assisting our clients in identifying, partnering with, and acquiring the cutting-edge solutions required for success. From strategic advisory to growth financing and M&A, our team's expertise consistently delivers outstanding results for our medical device clients.
Medical therapeutic and diagnostic devices are indispensable tools in contemporary healthcare, used for diagnosing, monitoring, and treating various diseases and health conditions. These devices are pivotal in medical practice, providing precise and reliable data that assist physicians in making well-informed decisions regarding patient care.
Diagnostic devices encompass a wide array of instruments and technologies designed to identify diseases or conditions. These include X-ray machines, MRI (magnetic resonance imaging) scanners, CT (computerized tomography) scanners, ultrasound machines, and endoscopes. Such devices allow doctors to obtain detailed images and data of the human body, essential for diagnosing diseases like cancer, cardiovascular diseases, and neurological disorders. Laboratory equipment for analyzing blood and tissue samples, such as blood analyzers and biopsy instruments, also constitute critical diagnostic tools.
Therapeutic devices are employed to treat existing illnesses or alleviate symptoms. These include dialysis machines for kidney failure, ventilators for respiratory diseases, and pacemakers for cardiac arrhythmia. Additionally, radiotherapy devices used for cancer treatment and physiotherapy devices for rehabilitation post-injuries or surgeries are significant components of this category.
In recent years, advanced technologies like robotic surgery and telemedicine devices have gained prominence, significantly enhancing the precision and accessibility of medical treatments. Robotic surgical systems facilitate minimally invasive procedures with greater accuracy and shorter recovery times. Telemedicine devices enable remote patient monitoring and provide access to medical advice even in isolated areas.
Medical therapy and diagnostic devices substantially enhance patient care by enabling more accurate diagnoses, more effective treatments, and improved monitoring of health conditions. Continuous development and innovation in this sector promise further advancements in medical practice and patient safety.
M&A activities in the medical medical therapeutic and diagnostic devices markets provide a competitive edge by acquiring innovative technologies or intellectual property, thereby offering unique solutions, attracting more customers, and increasing market share. Key drivers include market consolidation to enhance capabilities and product portfolios, and technological advancements like robotics and AI, which push companies to merge with firms possessing cutting-edge technologies. M&A also facilitates access to new geographic markets and diversification of product offerings. Additionally, these transactions aim for cost synergies and operational efficiencies, helping companies navigate complex regulatory landscapes and reimbursement challenges. Strategic partnerships also play a role, accelerating innovation and market penetration.
ConAlliance excels in supporting entrepreneurs, management teams, and owners in executing transactions (M&A) and securing financing through equity and debt within the realm of medical therapy and diagnostic devices. Our specialization is marked by exceptional technical expertise in corporate finance and a deep understanding of the medical therapy and diagnostic devices niche. With over 200 healthcare transactions to our credit, we provide professional advice to mid-sized companies, their shareholders, and investors. Our services are underpinned by an analytical approach, extensive experience, and an outstanding global network in the healthcare and medical technology industry.
Are you currently dealing with topics such as patent, technology or company sales or acquisitions? Then get in touch with us.
ConAlliance serves M&A advice to medical products companies in all major geographies, including medical supplies, capital equipment, implantable devices, and others.
In developed markets, our experience working with leading payors, providers, and regulators allows us to provide a unique advice when selling or buying a medical device company.
ConAlliance provides strategic advice on a full range of medical device transactions, including:
The most important medical device manufacturers worldwide are (among others): Johnson and Johnson , Medtronic , GE Healthcare , Cardinal Health , Baxter International, Tyco Healthcare, Kodak Health Group , Hospira , Smith & Nephew , Boston Scientific , Stryker , B. Braun , St. Jude Medical , Guidant Corp., Siemens Medical Solutions , Philips Medical Systems , Fresenius , 3M Healthcare , Zimmer Holdings , Becton, Dickinson & Co. , Synthes , Alcon , Biomet , C. R. Bard , Terumo , Dentsply International , Invacare , Gambro , Dräger Medical , Varian Medical ,
the authorization of medical products for human use as well as the supervision of pharmaceutical companies are shared by different German authorities on the national and federal state level.
In M&A it is important is important to distinguish, i.e. medicinal products, medical products, medical devices, food products or cosmetics. The difference, for example, between medicinal products and medical devices is of great importance for the manufacturer, because medicinal products only can be marketed after a marketing authorization has been granted. Medical devices, for example, must undergo only a conformity-assessment procedure which is faster and less costly than medicinal product authorization.
ConAlliance Investmentbanking advises in acquiring medical product companies in Europe.
The reimbursability of the target’s products has a very significant financial impact on the deal.
M&A advisory services
m&a healthcare
ConAlliance healthcare investment banking and M&A services reach from medical technology, healthcare services, information-driven healthcare technology, life science tools and diagnostics to biopharmaceuticals and medical devices and pharmaceutical companies.
acquire medical device business
Our clients cover a broad spectrum of sectors including companies engaged in the clinical development of new therapeutic compounds, drug discovery techniques, medical technologies and devices.
ConAlliance is an German investment banking firm that focuses exclusively on the health care industry. Our clients include medical technology companies, pharmaceutical and biotech companies, health care information technology, private equity and venture capital. ConAlliance has one of the most experienced healthcare M&A teams in Germany with subsidiaries and offices in the USA and China and the most important countries in Europe. Operating out of offices in Germany, ConAlliance provides mergers & acquisitions, strategic and financial advisory solutions for its healthcare clients.
Within the life sciende industry our services comprise mergers and acquisitions, private placements, valuations and fairness opinions, distressed M&A, ....
ConAlliance is the leading European M&A advisory firm with respect to mergers acquisitions of medical devices.
m&a medical products mergers & acquisitions investmentbanking
sell medical device company
medical devices include heart implants and orthopedic implants, but that only begins to scratch the surface. Surgical equipment, radiological equipment, stretchers, wheelchairs, and hospital beds all fall under the medical device category. Basically, if you go into a hospital, anything that "do[es] not achieve its intended use through chemical reaction and [is] not metabolized in the body" is considered devices.
Mergers and acquisitions is a perfect tool for healthcare companies to stimulate inorganic growth – that means growth through licences, acquisitions and partnerships.
ConAlliance has a significant track record in completed transactions within the wound care sector. Our M&A advisors do not only know about investment banking, but also have deep insights into the wound care business. Wound care companies develop a full line of products to actively promote wound healing, maintain moist wound healing environment and control bacteria.
We are a longstanding leader in advising healthcare M&A transactions with special emphasis on medical devices.